Article
ONE-CARBON METABOLISM AND CHEMOTHERAPY-INDUCED TOXICITIES IN PATIENTS WITH STAGE II-III COLORECTAL CANCER
2025-12-08
Abstract excerpt
<h4>Introduction: </h4> : One-carbon metabolism (OCM) is a target of the chemotherapeutic agent capecitabine. Here, we investigated pretreatment plasma OCM biomarker concentrations in relation to capecitabine-induced toxicities in patients with stage II-III colorectal cancer (CRC). <h4>Method: </h4> : Within a prospective cohort, 297 patients receiving adjuvant capecitabine-based chemotherapy were included. Pretr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0522a23d-c7fa-5259-92a6-2895258ec82f
- DOI
- 10.22541/au.176519726.65984080/v1
